Literature DB >> 849066

Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat.

R D Sofia, L C Knobloch, J J Harakal, D J Erikson.   

Abstract

Orally administered delta9-tetrahydrocannabinol (THC) produced a dose-dependent increase in urine output in hydrated rats similar in mg/kg potency and magnitude of effect to hydrochlorothiazide (HCT). Whereas HCT promoted marked excretion of Na+, K+ and Cl- and an increase in the urinary Na+/K+ at all diuretic doses (1.25-20.0 mg/kg), THC had only a slight effect on Na+ and K+ excretion but not Cl- even after the highest dose tested (20.0 mg/kg). Hypophysectomy and adrenalectomy abolished the diuretic effect of THC, thus suggesting both central and peripheral sites of action for the diuretic effect of THC. Tolerance to the effect on urine output by THC developed after 15 days of repeated dosing, while urine output and electrolyte excretion remained significantly elevated after 25 days of HCT administration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849066

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  9 in total

1.  Severe hyponatraemia during sepsis and marijuana addiction.

Authors:  Concetta Catalano; Sidy Seck; Giuseppe Enia
Journal:  BMJ Case Rep       Date:  2011-03-29

2.  Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a κ-Opioid Agonist in THC-Treated Mice.

Authors:  Girish R Chopda; Viraj Parge; Ganesh A Thakur; S John Gatley; Alexandros Makriyannis; Carol A Paronis
Journal:  J Pharmacol Exp Ther       Date:  2016-05-26       Impact factor: 4.030

3.  Diuretic effects of cannabinoids.

Authors:  Carol A Paronis; Ganesh A Thakur; Shama Bajaj; Spyros P Nikas; V Kiran Vemuri; Alexandros Makriyannis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2012-09-27       Impact factor: 4.030

4.  Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.

Authors:  Shi Di; Cherif Boudaba; Ion R Popescu; Feng-Ju Weng; Christina Harris; Victor L Marcheselli; Nicolas G Bazan; Jeffrey G Tasker
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

Review 5.  Anandamide and its metabolites: what are their roles in the kidney?

Authors:  Joseph K Ritter; Guangbi Li; Min Xia; Krishna Boini
Journal:  Front Biosci (Schol Ed)       Date:  2016-06-01

6.  The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.

Authors:  Julien C Dodu; Rebecca K Moncayo; M Imad Damaj; Joel E Schlosburg; Hamid I Akbarali; Lesley D O'Brien; Debra A Kendall; Zhixing Wu; Dai Lu; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2021-10-08       Impact factor: 4.402

7.  Diuretic effects of cannabinoid agonists in mice.

Authors:  Girish R Chopda; V Kiran Vemuri; Rishi Sharma; Ganesh A Thakur; Alexandros Makriyannis; Carol A Paronis
Journal:  Eur J Pharmacol       Date:  2013-10-05       Impact factor: 4.432

8.  Mechanism of Diuresis and Natriuresis by Cannabinoids: Evidence for Inhibition of Na+-K+-ATPase in Mouse Kidney Thick Ascending Limb Tubules.

Authors:  Joseph K Ritter; Ashfaq Ahmad; Shobha Mummalaneni; Zdravka Daneva; Sara K Dempsey; Ningjun Li; Pin-Lan Li; Vijay Lyall
Journal:  J Pharmacol Exp Ther       Date:  2020-10-21       Impact factor: 4.030

Review 9.  Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox.

Authors:  Myriam Dao; Helene François
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-07       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.